The global topical cyanoacrylates market size was estimated at USD 97.5 million in 2024, and is projected to reach USD 160.2 million by 2033, growing at a CAGR of 5.65% from 2025 to 2033. The market growth is primarily driven by increasing demand for advanced wound closure and tissue adh... Read More »
June 2025The global infant nutrition market size was valued at USD 392.1 million in 2024 and is projected to reach USD 611.1 million by 2030, growing at a CAGR of 7.7% from 2025 to 2030. The market growth is driven by factors such as increasing awareness and acceptance of infant nutrition product... Read More »
June 2025The global herbal supplements market size was estimated at USD 42.33 billion in 2024 and is anticipated to reach USD 90.24 billion in 2033, growing at a CAGR of 8.89% from 2025 to 2033. This growth is driven by rising consumer health consciousness, a growing preference for natural and pl... Read More »
June 2025The global poultry medicine market size was estimated at USD 6.72 billion in 2024 and is projected to reach USD 11.90 billion by 2033, growing at a CAGR of 6.70% from 2025 to 2033. The market is advancing, driven by the growing prevalence of poultry diseases, rising demand for poultry pr... Read More »
June 2025The U.S. hemodialysis catheter market size was estimated at USD 408.14 million in 2024 and is projected to reach USD 741.41 million by 2033, growing at a CAGR of 6.9% from 2025 to 2033. The demand for hemodialysis catheters is increasing in the U.S. due to the rising prevalence of kidney... Read More »
June 2025The global rozanolixizumab (Rystiggo) market size was estimated at USD 218.61 million in 2024 and is projected to reach USD 1,700.40 million by 2033, growing at a CAGR of 15.22% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greate... Read More »
June 2025The global hospital electronic health records market size was estimated at USD 17.69 billion in 2024 and is projected to reach USD 26.11 billion by 2033, growing at a CAGR of 4.51% from 2025 to 2033. The market demand is attributed to the rise in hospitals adopting electronic health reco... Read More »
June 2025The global fitness tracker for sleep monitoring market size was estimated at USD 6.01 billion in 2024 and is projected to reach USD 23.05 billion by 2033, growing at a CAGR of 15.98 % from 2025 to 2033. The growth is attributed to factors such as lifestyle shifts, rising health conscious... Read More »
June 2025The global small-scale bioreactors market size was estimated at USD 1.12 billion in 2024 and is projected to reach USD 2.49 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. This growth is primarily driven by the increasing use of small-scale bioreactors in the pharmaceutical... Read More »
June 2025The global cancer gene therapy market size was estimated at USD 4.51 billion in 2024 and is anticipated to reach USD 12.76 billion in 2030, growing at a CAGR of 19.34% from 2025 to 2030. The significant growth can primarily be attributed to the rising demand for gene therapy and the incr... Read More »
June 2025The U.S. augmented reality and virtual reality in healthcare market size was estimated at USD 1.03 billion in 2024 and is projected to grow at a CAGR of 15.4% from 2025 to 2030. Advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous star... Read More »
June 2025The U.S. keytruda market size was estimated at USD 17.87 billion in 2024 and is projected to decline at a CAGR of -3.12% from 2025 to 2033. The market faces challenges from the impending patent expiration in 2028, introducing biosimilar competition. Although the decline is expected, mark... Read More »
June 2025The U.S. anti-aging supplements market was valued at USD 1.39 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. Growth is driven by increasing health consciousness, rising life expectancy, and a proactive approach to age-related health management among U.S. con... Read More »
June 2025The U.S. cardiac rhythm management devices market size was estimated at USD 6.8 billion in 2024 and is projected to grow at a CAGR of 6.6% from 2025 to 2033. The U.S. cardiac rhythm management market is advancing through a convergence of growing clinical demand, evolving device technolog... Read More »
June 2025The U.S. balloon valvuloplasty devices market size was estimated at USD 820.1 million in 2024 and is expected to grow at a CAGR of 3.4% from 2025 to 2033. Rheumatic heart disease (RHD) is a critical cardiovascular disorder caused by permanent damage to the heart valves following an episo... Read More »
June 2025The Middle East & Africa continuous glucose monitoring devices market size was estimated at USD 391.7 million in 2024 and is expected to grow at a CAGR of 11.8% from 2025 to 2033 to reach a value of USD 1,072.2 million in 2033. This growth is fueled by the alarming rise in diabetes c... Read More »
June 2025The U.S. multiomics services market size was valued at USD 398.7 million in 2024 and is projected to grow at a CAGR of 17.10% from 2025 to 2033. This growth is primarily driven by increasing demand for personalized medicine, the rising prevalence of chronic and complex diseases, and the ... Read More »
June 2025The U.S. topical cyanoacrylates market size was estimated at USD 31.65 million in 2024 and is expected to grow at a CAGR of 5.10% from 2025 to 2033. The market growth is attributed to the increasing demand for fast-acting, non-invasive wound closure solutions in both clinical and home ca... Read More »
June 2025The U.S. invisible orthodontics market size was estimated at USD 3.52 billion in 2024 and is projected to reach USD 39.76 billion by 2033, growing at a CAGR of 31.6% from 2025 to 2033. Invisible orthodontics refers to teeth-straightening treatments that use clear or hidden appliances, su... Read More »
June 2025The U.S. Rozanolixizumab (Rystiggo) market size was estimated at USD 199.13 million in 2024 and is expected to grow at a CAGR of 7.30% from 2025 to 2033. The U.S. Rozanolixizumab (Rystiggo) market focuses on treating generalized myasthenia gravis (gMG) in adults with anti-AChR or anti-Mu... Read More »
June 2025